AbbVie Inc.

    Jurisdiction
    United States
    LEI
    FR5LCKFTG8054YNNRU85
    ISIN
    US00287Y1091 (ABBV)
    Sectors
    1. Healthcare
    2. Drug Manufacturers - General

    Scores

    InsiderPie Expert Score
    71 / 100
    Better than peer group:
    62 / 100
    Fair value (Benjamin Graham formula)
    €184.02 8.0% overvalued
    Financial strength (Piotroski F-Value)
    6 / 9
    Fundamental strength relative to industry (Mohanram G-Value)
    3 / 7

    Profile

    AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. Read full profile

    Fundamentals

    Net revenue
    €49.75B
    Gross margin
    74.3%
    EBIT
    €10.18B
    EBIT margin
    20.5%
    Net income
    €3.21B
    Net margin
    6.5%

    Statement period: - (published )

    Estimates

    Fiscal Year Net revenue Net income
    €56.40B +13.4% €21.58B +571.3%
    €60.58B +7.4% €24.10B +11.7%
    €64.72B +6.8% €26.61B +10.4%

    Stock price

    Stock price loading... No stock price available Stock price provided by Lang & Schwarz Steigende Zinsen und niedrigere Bewertungen für Wachstumsaktien im Allgemeinen Eine Gewinnwarnung beim Konkurrenten Adyen signalisiert eine Abkühlung des europäischen Markts für Zahlungsdienstleistungen. Eine Gewinnwarnung von Wordline SA triggert einen massiven Kursverlust.

    Configure chart

    Adjust colors to be more accessible for red-green-colorblind users.
    Scale
    Moving average Display a moving average line on the chart.

    Dividends

    Last dividend amount
    $1.64
    Ex date
    Payment date
    Dividend payout ratio
    300.8%

    Analyst ratings

    No analyst ratings available

    Insider Transactions

    Name Title Transaction Date Shares Price Value
    SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER -42K $198.42 -$8.41M
    Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER -13K $198.51 -$2.64M

    Congress transactions

    Name Transaction date Value
    Julie Johnson September 11, 2025 $1.00K–$15.00K
    John Boozman August 22, 2025 $1.00K–$15.00K
    Ritchie Torres August 20, 2025 $1.00K–$15.00K
    Ritchie Torres August 20, 2025 $1.00K–$15.00K
    Marjorie Greene August 15, 2025 $1.00K–$15.00K

    Investor transactions

    Name Shares Value Last change Change type
    Peter Brown 1.2M $256.05M +249K Buy
    Ray Dalio 105K $21.99M -181K Sell

    Earnings Calls

    Add to watchlist

    Notifications